Rationale and Preclinical Data Supporting Bariatric Arterial Embolization

Research output: Contribution to journalReview article


The prevalence of obesity is increasing globally, leading to significantly increased morbidity, mortality, and health care costs. However, there is a lack of effective treatment options that can treat patients with obesity less invasively than with bariatric surgery. Bariatric arterial embolization (BAE) is an image-guided, minimally invasive, percutaneous procedure that is currently being investigated in preclinical animal models and early clinical trials. If successful, BAE may represent a viable interventional approach for obesity treatment. The purpose of this article is to introduce the physiological and anatomical rationale for BAE, review techniques involved in performing BAE for weight modulation, and provide up-to-date preclinical evidence that supports the translation of BAE into patients.

Original languageEnglish (US)
Article number100656
JournalTechniques in Vascular and Interventional Radiology
Issue number1
StatePublished - Mar 2020


  • Bariatric embolization
  • Embolics
  • Ghrelin
  • Obesity
  • Weight loss

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Rationale and Preclinical Data Supporting Bariatric Arterial Embolization'. Together they form a unique fingerprint.

  • Cite this